NO962535L - Di-tert-butylphenol compounds useful as anti-inflammatory agents - Google Patents

Di-tert-butylphenol compounds useful as anti-inflammatory agents

Info

Publication number
NO962535L
NO962535L NO962535A NO962535A NO962535L NO 962535 L NO962535 L NO 962535L NO 962535 A NO962535 A NO 962535A NO 962535 A NO962535 A NO 962535A NO 962535 L NO962535 L NO 962535L
Authority
NO
Norway
Prior art keywords
tert
inflammatory agents
compounds useful
butylphenol compounds
integer
Prior art date
Application number
NO962535A
Other languages
Norwegian (no)
Other versions
NO962535D0 (en
Inventor
Thomas Hod Hudec
Maurice Edward Loomans
Joel Ira Shulman
Original Assignee
Procter & Gamble
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Procter & Gamble filed Critical Procter & Gamble
Publication of NO962535D0 publication Critical patent/NO962535D0/en
Publication of NO962535L publication Critical patent/NO962535L/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/12Ketones
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/04Centrally acting analgesics, e.g. opioids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pain & Pain Management (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Engineering & Computer Science (AREA)
  • Neurosurgery (AREA)
  • Rheumatology (AREA)
  • Epidemiology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

Oppfinnelsen vedrører preparater omfattende: (a) en sikker og effektiv mengde av en forbindelse med strukturformelen (i) hvor n er et helt tall fra l til omtrent 5, m er et helt tall fra O til omtrent 3, -R er hydrogen eller rettkjedet eller forgrenet Cj-C^-alkanyl, og (b) en farmasøytisk tålbar bærer. Oppfinnelsen vedrører også metoder for å behandle sykdommer som er kjennetegnet ved inflammasjon og/eller smerte, som reumatoid artritt og osteoartritt, ved å administrere en sikker og effektiv mengde av denne forbindelse til et menneske eller lavere dyr med behov for slik behandling.The invention relates to compositions comprising: (a) a safe and effective amount of a compound of structural formula (i) wherein n is an integer from 1 to about 5, m is an integer from 0 to about 3, -R is hydrogen or straight chain or branched Cj-C ^ alkanyl, and (b) a pharmaceutically tolerable carrier. The invention also relates to methods of treating diseases characterized by inflammation and / or pain, such as rheumatoid arthritis and osteoarthritis, by administering a safe and effective amount of this compound to a human or lower animal in need of such treatment.

NO962535A 1993-12-17 1996-06-14 Di-tert-butylphenol compounds useful as anti-inflammatory agents NO962535L (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US16934793A 1993-12-17 1993-12-17
PCT/US1994/014405 WO1995016443A1 (en) 1993-12-17 1994-12-16 Di-tert-butylphenol compounds useful as anti-inflammatory agents

Publications (2)

Publication Number Publication Date
NO962535D0 NO962535D0 (en) 1996-06-14
NO962535L true NO962535L (en) 1996-08-15

Family

ID=22615292

Family Applications (1)

Application Number Title Priority Date Filing Date
NO962535A NO962535L (en) 1993-12-17 1996-06-14 Di-tert-butylphenol compounds useful as anti-inflammatory agents

Country Status (13)

Country Link
EP (1) EP0734256A1 (en)
JP (1) JPH09506624A (en)
CN (1) CN1137752A (en)
AU (1) AU702254B2 (en)
BR (1) BR9408334A (en)
CA (1) CA2179009A1 (en)
CZ (1) CZ285436B6 (en)
HU (1) HUT74507A (en)
NO (1) NO962535L (en)
NZ (1) NZ277986A (en)
PL (1) PL315061A1 (en)
SK (1) SK76996A3 (en)
WO (1) WO1995016443A1 (en)

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4130666A (en) * 1977-05-16 1978-12-19 Riker Laboratories, Inc. Anti-inflammatory method
US5280045A (en) * 1991-10-16 1994-01-18 The Procter & Gamble Company 4(3,5-bis(1,1-dimethylethyl-4-hydroxyphenyl)-4-oxobutanamide compound useful as an anti-inflammatory agent

Also Published As

Publication number Publication date
CA2179009A1 (en) 1995-06-22
EP0734256A1 (en) 1996-10-02
JPH09506624A (en) 1997-06-30
CN1137752A (en) 1996-12-11
BR9408334A (en) 1997-08-19
SK76996A3 (en) 1997-05-07
WO1995016443A1 (en) 1995-06-22
NZ277986A (en) 1998-03-25
HUT74507A (en) 1997-01-28
HU9601656D0 (en) 1996-08-28
CZ285436B6 (en) 1999-08-11
AU702254B2 (en) 1999-02-18
PL315061A1 (en) 1996-09-30
AU1372295A (en) 1995-07-03
NO962535D0 (en) 1996-06-14
CZ175596A3 (en) 1996-11-13

Similar Documents

Publication Publication Date Title
RU94044671A (en) Use of nonpeptide antagonists of tachykinin receptors
ES2165969T3 (en) AROMATIC CONDENSED NITROGEN COMPOUNDS 5.5 ARIL-SUBSTITUTED AS ANTI-INFLAMMATORY AGENTS.
RU94036758A (en) Use of 2-phenyl-3-aroylbenzothiophenes for peri-menopause syndrome
ATE219363T1 (en) SOLUBLE PRODRUGS OF PACLITAXEL
GR850126B (en)
UA48939C2 (en) Disubstituted furanons, methods for synthesis, pharmaceutical composition, method for treating inflammatory disease, intermediate substances
FI945599A0 (en) Phosphonocarboxylate compounds for the treatment of abnormal calcium and phosphate metabolism
DE69825603D1 (en) 2,3,5-TRISUBSTITUTED PYRIDINE AS INHIBITORS OF CYCLOOXYGENASE-2
MX9701819A (en) Dihydrobenzofuran and related compounds useful as anti-inflammatory agents.
RU94036771A (en) Inhibitors of angiogenesis and anriogenic disease
RU94044454A (en) Inhibitor of autoimmune diseases
RU94037246A (en) Use of 2-phenyl-3-aroylbenzothiophenes for cartilage destruction inhibition
RU94038256A (en) Derivatives of pyrazolopyrimidine, method of their synthesis, pharmaceutical compositions based on thereof
RU94037233A (en) Use of 2-phenyl-3-aroylbenzothiophenes for drug-resistant neoplasma treatment
RU94044356A (en) Use of 2-phenyl-3-aroylbenzothiophenes for thrombodulin expression increase to inhibit thrombotic disorder, for protein c activation
MY120318A (en) Mixture of primary fatty acids of high molecular weight obtained from sugar cane wax and its pharmaceutical uses.
MX9803901A (en) Sulfur containing di-tert-butylphenol compounds useful as anti-inflammatory agents.
NO985679D0 (en) Dihydrobenzopyran and related compounds useful as anti-inflammatory agents
RU94045156A (en) Use of 2-phenyl-3-aroylbenzothiophenes for premature sexual maturation inhibition
DK0986393T3 (en) Use of a nitroxide or a prodrug thereof in the prophylactic and therapeutic treatment of cancer
RU94046106A (en) Quaternary nitrogen-containing phosphonate compounds for treatment of anomal calcium and phosphate metabolism and also for prophylaxis and treatment of dental deposits and stones, pharmaceutical compositions, method of treatment
JPS6470417A (en) Method and composition for treating psoriasis
RU94046456A (en) New vitamin d analogs, preparation process, pharmaceutical composition, and method or treatment
NO962535L (en) Di-tert-butylphenol compounds useful as anti-inflammatory agents
MX9806252A (en) Dihydrobenzofuran compounds useful as anti-inflammatory agents.

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application